Free Trial

Bed Bath & Beyond chief financial officer Gustavo Arnal dies

UNION, N.J. (AP) — Gustavo Arnal, the chief financial officer of retail chain Bed Bath & Beyond, has died, the company confirmed on Sunday.

The company said Arnal died on Friday. According to the New York City Police Department, police found the 52-year-old unconscious with injuries showing he fell from a building in Manhattan. He was pronounced dead in the scene and the New York City Medical Examiner’s Office will determine the cause of death. Police said an investigation was ongoing.

Arnal joined the company in May 2020 after previous stints at Avon, Walgreens Boots Alliance and Procter & Gamble.

"Gustavo will be remembered by all he worked with for his leadership, talent and stewardship of our Company. I am proud to have been his colleague, and he will be truly missed by all of us at Bed Bath & Beyond and everyone who had the pleasure of knowing him,” said Harriet Edelman, independent chair of the company's board, in Sunday's statement.

Bed Bath & Beyond has faced turbulence recently: Its shares made a monstrous run from $5.77 to $23.08 over a little more than two weeks in August, in trading reminiscent of last year’s meme-stock craze, when out-of-favor companies suddenly became darlings of smaller-pocketed investors. On Wednesday, the company said it would shutter stores and lay off workers in a bid to turn around its beleaguered business.

The home goods retailer based in Union, New Jersey, said it will close about 150 of its namesake stores and slash its workforce by 20%.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRankâ„¢Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Procter & Gamble (PG)
4.8352 of 5 stars
$161.201.2%2.62%25.59Moderate Buy$178.45
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

3 Defense Stocks Under $10 With Massive Upside
NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines